Tilray Brands, Inc. Professional Fees
Tilray Brands, Inc. (TLRY) reported Professional Fees of $4.24 million for the 12-month period ending 2026-05-31, per its 10-K filed 2026-07-28.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ProfessionalFees · last filed 2026-07-28
- Tilray Brands, Inc. professional fees for the quarter ending 2026-05-31 was $896.00K, a 19.21% decline year-over-year.
- Tilray Brands, Inc. professional fees for the quarter ending 2026-02-28 was $1.09M, a 19.38% decline year-over-year.
- Tilray Brands, Inc. professional fees for the quarter ending 2025-11-30 was $1.03M, a 8.17% decline year-over-year.
- Tilray Brands, Inc. professional fees for the quarter ending 2025-08-31 was $1.22M, a 3.40% increase year-over-year.
- Tilray Brands, Inc. professional fees for fiscal 2026 was $4.24M, a 11.06% decline from fiscal 2025.
- Tilray Brands, Inc. professional fees for fiscal 2025 was $4.76M, a 10.85% decline from fiscal 2024.
- Tilray Brands, Inc. professional fees for fiscal 2024 was $5.34M, a 25.41% decline from fiscal 2023.
- Tilray Brands, Inc. professional fees for fiscal 2023 was $7.17M, a 45.08% decline from fiscal 2022.
| Period end | Professional Fees 3 month | Professional Fees 6 month | Professional Fees 9 month | Professional Fees 12 month | Professional Fees 12 month as first filed |
|---|---|---|---|---|---|
| 2026-05-31 | $896.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-28 | $1.99M derived: sum of 2 quarters · filed 2026-07-28 | $3.02M derived: sum of 3 quarters · filed 2026-07-28 | $4.24M 10-K · filed 2026-07-28 | |
| 2026-02-28 | $1.09M 10-Q · filed 2026-04-01 | $2.12M derived: sum of 2 quarters · filed 2026-04-01 | $3.34M 10-Q · filed 2026-04-01 | $4.45M derived: sum of 4 quarters · filed 2026-07-28 | |
| 2025-11-30 | $1.03M 10-Q · filed 2026-01-08 | $2.25M 10-Q · filed 2026-01-08 | $3.36M derived: sum of 3 quarters · filed 2026-07-28 | $4.71M derived: sum of 4 quarters · filed 2026-07-28 | |
| 2025-08-31 | $1.22M 10-Q · filed 2025-10-09 | $2.33M derived: sum of 2 quarters · filed 2026-07-28 | $3.68M derived: sum of 3 quarters · filed 2026-07-28 | $4.80M derived: sum of 4 quarters · filed 2026-07-28 | |
| 2025-05-31 | $1.11M derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-28 | $2.46M derived: sum of 2 quarters · filed 2026-07-28 | $3.59M derived: sum of 3 quarters · filed 2026-07-28 | $4.76M 10-K · filed 2026-07-28 | |
| 2025-02-28 | $1.35M 10-Q · filed 2026-04-01 | $2.48M derived: sum of 2 quarters · filed 2026-04-01 | $3.66M 10-Q · filed 2026-04-01 | $4.34M derived: sum of 4 quarters · filed 2026-07-28 | |
| 2024-11-30 | $1.13M 10-Q · filed 2026-01-08 | $2.30M 10-Q · filed 2026-01-08 | $2.99M derived: sum of 3 quarters · filed 2026-07-28 | $3.65M derived: sum of 4 quarters · filed 2026-07-28 | |
| 2024-08-31 | $1.18M 10-Q · filed 2025-10-09 | $1.86M derived: sum of 2 quarters · filed 2026-07-28 | $2.52M derived: sum of 3 quarters · filed 2026-07-28 | $5.02M derived: sum of 4 quarters · filed 2026-07-28 | |
| 2024-05-31 | $687.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-28 | $1.34M derived: sum of 2 quarters · filed 2026-07-28 | $3.85M derived: sum of 3 quarters · filed 2026-07-28 | $5.34M 10-K · filed 2026-07-28 | |
| 2024-02-29 | $656.00K 10-Q · filed 2025-04-08 | $3.16M derived: sum of 2 quarters · filed 2025-04-08 | $4.66M 10-Q · filed 2025-04-08 | $6.44M derived: sum of 4 quarters · filed 2025-07-29 | |
| 2023-11-30 | $2.50M 10-Q · filed 2025-01-10 | $4.00M 10-Q · filed 2025-01-10 | $5.78M derived: sum of 3 quarters · filed 2025-07-29 | $6.95M derived: sum of 4 quarters · filed 2025-07-29 | |
| 2023-08-31 | $1.50M 10-Q · filed 2024-10-10 | $3.28M derived: sum of 2 quarters · filed 2025-07-29 | $4.45M derived: sum of 3 quarters · filed 2025-07-29 | $6.17M derived: sum of 4 quarters · filed 2025-07-29 | |
| 2023-05-31 | $1.78M derived: 10-K 12 month − 10-Q 9 month · filed 2025-07-29 | $2.95M derived: sum of 2 quarters · filed 2025-07-29 | $4.68M derived: sum of 3 quarters · filed 2025-07-29 | $7.17M 10-K · filed 2025-07-29 | |
| 2023-02-28 | $1.17M 10-Q · filed 2024-04-09 | $2.90M derived: sum of 2 quarters · filed 2024-04-09 | $5.38M 10-Q · filed 2024-04-09 | $8.76M derived: sum of 4 quarters · filed 2024-10-10 | |
| 2022-11-30 | $1.73M 10-Q · filed 2024-01-09 | $4.22M 10-Q · filed 2024-01-09 | $7.60M derived: sum of 3 quarters · filed 2024-10-10 | $11.20M derived: sum of 4 quarters · filed 2024-10-10 | |
| 2022-08-31 | $2.49M 10-Q · filed 2024-10-10 | $5.87M derived: sum of 2 quarters · filed 2024-10-10 | $9.47M derived: sum of 3 quarters · filed 2024-10-10 | $12.82M derived: sum of 4 quarters · filed 2024-10-10 | |
| 2022-05-31 | $3.38M derived: 10-K 12 month − 10-Q 9 month · filed 2024-07-30 | $6.98M derived: sum of 2 quarters · filed 2024-07-30 | $10.33M derived: sum of 3 quarters · filed 2024-07-30 | $13.05M 10-K · filed 2024-07-30 | |
| 2022-02-28 | $3.60M 10-Q · filed 2023-04-10 | $6.96M derived: sum of 2 quarters · filed 2023-04-10 | $9.67M 10-Q · filed 2023-04-10 | $12.66M derived: sum of 4 quarters · filed 2023-07-26 | |
| 2021-11-30 | $3.35M 10-Q · filed 2023-01-09 | $6.07M 10-Q · filed 2023-01-09 | $9.06M derived: sum of 3 quarters · filed 2023-07-26 | ||
| 2021-08-31 | $2.71M 10-Q · filed 2022-10-07 | $5.71M derived: sum of 2 quarters · filed 2023-07-26 | |||
| 2021-05-31 | $2.99M derived: 10-K 12 month − 10-Q 9 month · filed 2023-07-26 | $11.78M 10-K · filed 2023-07-26 | $5.15M 10-K · filed 2021-07-28 | ||
| 2021-03-31 | $3.58M 10-Q · filed 2021-05-10 | ||||
| 2021-02-28 | $2.68M 10-Q · filed 2022-04-06 | $8.79M 10-Q · filed 2022-04-06 | |||
| 2020-12-31 | $3.02M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-19 | $12.77M 10-K · filed 2021-02-19 | |||
| 2020-11-30 | $3.17M 10-Q · filed 2022-01-10 | $6.11M 10-Q · filed 2022-01-10 | |||
| 2020-09-30 | $1.41M 10-Q · filed 2020-11-09 | $9.75M 10-Q · filed 2020-11-09 | |||
| 2020-08-31 | $2.94M 10-Q · filed 2021-10-07 | ||||
| 2020-06-30 | $3.82M 10-Q · filed 2020-08-10 | $8.34M 10-Q · filed 2020-08-10 | $16.82M derived: sum of 3 quarters · filed 2021-05-10 | $22.87M derived: sum of 4 quarters · filed 2021-05-10 | |
| 2020-05-31 | $14.19M 10-K · filed 2022-07-28 | $4.92M 10-K · filed 2021-07-28 | |||
| 2020-03-31 | $4.52M 10-Q · filed 2021-05-10 | $12.99M derived: sum of 2 quarters · filed 2021-05-10 | $19.05M derived: sum of 3 quarters · filed 2021-05-10 | $23.25M derived: sum of 4 quarters · filed 2021-05-10 | |
| 2019-12-31 | $8.47M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-19 | $14.52M derived: sum of 2 quarters · filed 2021-02-19 | $18.73M derived: sum of 3 quarters · filed 2021-02-19 | $21.19M 10-K · filed 2021-02-19 | |
| 2019-09-30 | $6.05M 10-Q · filed 2020-11-09 | $10.26M derived: sum of 2 quarters · filed 2020-11-09 | $12.72M 10-Q · filed 2020-11-09 | $16.18M derived: sum of 4 quarters · filed 2021-02-19 | |
| 2019-06-30 | $4.21M 10-Q · filed 2020-08-10 | $6.67M 10-Q · filed 2020-08-10 | $10.13M derived: sum of 3 quarters · filed 2021-02-19 | $11.57M derived: sum of 4 quarters · filed 2021-02-19 | |
| 2019-05-31 | $8.92M 10-K · filed 2021-07-28 | ||||
| 2019-03-31 | $2.46M 10-Q · filed 2020-05-11 | $5.92M derived: sum of 2 quarters · filed 2021-02-19 | $7.36M derived: sum of 3 quarters · filed 2021-02-19 | $8.53M derived: sum of 4 quarters · filed 2021-02-19 | |
| 2018-12-31 | $3.46M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-19 | $4.90M derived: sum of 2 quarters · filed 2021-02-19 | $6.08M derived: sum of 3 quarters · filed 2021-02-19 | $7.56M 10-K · filed 2021-02-19 | |
| 2018-09-30 | $1.44M 10-Q · filed 2019-11-13 | $2.61M derived: sum of 2 quarters · filed 2019-11-13 | $4.09M 10-Q · filed 2019-11-13 | ||
| 2018-06-30 | $1.17M 10-Q · filed 2019-08-13 | $2.66M 10-Q · filed 2019-08-13 | |||
| 2018-03-31 | $1.48M 10-Q · filed 2019-05-15 | ||||
| 2017-12-31 | $1.72M 10-K · filed 2020-03-02 | ||||
| 2016-12-31 | $424.00K 10-K · filed 2019-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Canopy Growth Corp (CGC) | $0.395B | ||
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |